🔗: https://t.co/bgR1qcw3aI "The goal is to make this tech available to any woman having a screening mammogram anywhere in the world," said Graham A. Colditz, MD. The AI-based tech, which earned FDA Breakthrough Device designation, was co-developed with Shu (Joy) Jiang, PhD.
Our new study shows adding prior/repeated mammogram images can substantially improve 5-year risk prediction for breast cancer! @gcolditz@rtamimi Debbie Bennett, Bernard Rosner, @washumedicine
https://t.co/w6SlQQNlna
🧵 Just published: USPSTF recommends all women undergo routine #breastcancer screening every other year beginning at age 40, an update from the 2016 recommendation to start at age 50.
https://t.co/xDPK4qu7JH
Our division opens doors for investigators across disciplines to connect and collaborate on projects that prevent cancer and other diseases, promote population health, and improve quality and access to health care in the region. Learn more: https://t.co/ORLGKKwMoM
The Division of Public Health Sciences is happy to welcome @theNCI's Peter Kraft, PhD, as our visiting guest lecturer for his discussion about the genetic epidemiology of breast cancer on Tuesday, March 12. Email Faith Tyler to register: [email protected].
Attend the next Office Hours @WashUOTM on “Healthtech AI” March 14th from 3-4pm. Discussions on regulatory constraints and state of Healthtech AI.
Panelists to include: @JoyJiang93 Graham A. Colditz, MD, DrPH, and @JohnKuelper
Info/Register > https://t.co/BXx0ZhJYLE
Great to see novel outcomes from our collaboration with St Jude. @WUSTLphs@SitemanCenter Plant Foods Intake and Risk of Premature Aging in Adult Survivors of Childhood Cancer in the St Jude Lifetime Cohor… https://t.co/uoy2N6t27R
Congratulations to @WashUSurgery's Shu Joy Jiang, PhD, @JoyJiang93, and all the #Equalize2024 participants!
Jiang will compete in the Digital Tools category of @EqualizeStartups, a pitch competition and symposium to empower academic women entrepreneurs.
Work by our beloved @WUSTLphs researchers is included in the EGRP's Research Highlights for 2023. Congratulations to the team on this nomination and this very successful publication!
Simin Cheng, MS, Graham Colditz, MD, DrPH, Shu (Joy) Jiang, PhD, and @MIRimaging's Debbie Bennett, MD, propose a novel approach for improved accuracy/efficiency for pectoral muscle removal in mammography images. Read the article in Cancer Causes & Control: https://t.co/eAPzCB33a0
Wonderful and honored to see our paper on longitudinal mammograms analysi and breast canceer risk @JAMAOnc in the NCI Epidemiology and Genomics Reasearch Program 2023 Research Highlights @joyjiang93@SitemanCenter@WUSTLphs@MIRimaging . See NCI sotry: https://t.co/igpQjDUwlR
Very exicited to receive the Gap funding! We are eager to push our methods towards clinical translation aiming for a more intelligent and automated pathology diagnosis
Gifts to the Cancer Frontier Fund at The Foundation for Barnes-Jewish Hospital recently funded two WashU Public Health Sciences projects through the Siteman Investment Program. Ashley Housten, OTD, MSCI, and Shu (Joy) Jiang, PhD, received SIP awards for their projects. Congrats!